Navigation Links
Hillcrest Completes Purchase of SouthCrest & Claremore Hospitals
Date:9/1/2011

TULSA, Okla., Sept. 1, 2011 /PRNewswire/ -- Hillcrest HealthCare System (HHS) has successfully completed the purchase of SouthCrest Hospital in Tulsa, Okla., and Claremore Regional Hospital in Claremore, Okla.  The price and financial terms of the agreement were not disclosed.

The transaction included the assets and operations of the 180-bed SouthCrest Hospital, the 89-bed Claremore Regional Hospital, more than 70 primary care physicians, specialists and mid-level providers and 1,100 employees.

"This is a milestone day for Hillcrest, its patients and residents of south Tulsa and Rogers County," said Kevin J. Gross, CEO of HHS and president of the Oklahoma Division of Ardent Health Services.  "We can now provide more access to quality health care for our patients, offer a network of 230 exceptional physicians and begin to invest and expand the capabilities at both SouthCrest and Claremore Regional."

The first part of that expansion is already under way.  The construction of two new heart catheterization labs has begun at SouthCrest Hospital.  It's an investment of $3.2 million.  At Claremore Regional, interventional cath procedures will be introduced later this month and an $800,000 internal facilities update will soon be completed that includes walls, floors and ceiling renovations.

HHS has also appointed Joseph Neely as chief executive officer of SouthCrest Hospital.  Neely brings more than 35 years of experience in health care administration to SouthCrest – much of it in south Tulsa.  Neely was previously senior vice president and administrator for Saint Francis Hospital South.  He also worked more than six years for HHS in the late 1990s.

"Joe is a team-builder and is proven in developing great relationships with physicians," said Gross.  "He will be a benefit to our patients, our employees and this community as we begin a new era at SouthCrest."

In the coming w
'/>"/>

SOURCE Hillcrest HealthCare System
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 /PRNewswire/  -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the patented biopharmaceutical, modernized traditional Chinese ... (API) released unaudited preliminary financial results for the ... Fiscal Year 2015 Ended September 30, 2014 Financial ... with $14.7 million in 1Q14 with gross margins ...
(Date:12/24/2014)... , Dec. 24, 2014  Conkwest, Inc., ... developing the proprietary Natural Killer (NK) cell-line platform, ... Dr. Patrick Soon-Shiong , NantWorks founder, physician ... definitive agreement to purchase approximately $48 million of ... with the investment, he will be named Co-Chairman ...
(Date:12/24/2014)... Dec. 23, 2014 PuraMed BioScience®, Inc., (OTC ... (OTC) medicinal and healthcare products, announced it received the ... a hemp-based, advanced headache relief product, for planned distribution ... Colorado , Washington State ... With the MigraPure H Advanced headache relief gel formulation ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
(Date:12/25/2014)... 26, 2014 The report “TS-1 (Colorectal ... on the current treatment landscape, unmet needs, current pipeline ... is an anti-cancer drug which is typically used for ... also used for treating gastric cancer and pancreatic cancer. ... The drug was first approved in 1999 in Japan ...
(Date:12/25/2014)... The short film “Color of Honor” by young ... a true 9/11 hero, Welles Remy Crowther. It has been ... hours of Nuremberg International Short Film Festival and the 8th ... screenwriter and director Luciana Lagana plays the mother of ... husband, Gregory Graham - Graham plays a heroic ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping ... of the models at LunaDress.co.uk come with big discounts, up to ... veil can turn out to be a most exciting memory and ... always bring surprise to a wedding. On the updated fashion blog, ... veils for a big day . , Going out with friends ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... closing in on a "fountain of youth" drug that can ... older adults, a new study suggests. Seniors received a ... that targets a genetic signaling pathway linked to aging and ... The experimental medication, a version of the drug ...
(Date:12/25/2014)... December 25, 2014 Residents at ... Community, recently showed their generous spirit by providing ... Catawba County Parenting Network- Grandparents Raising Grandchildren program. ... gathered around the largest Christmas tree on the ... purchased by residents of the Abernethy Village Association ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2
... Feb. 3 Arobella Medical, LLC, today ... the design, development,manufacturing, test, and delivery of ... Organization for Standardization (ISO), is the,regulatory standard ... closely,related to ISO 9000 and EN 46000. ...
... CLEVELAND, Feb. 3 Prayers From Maria - Children,s Glioma,Cancer Foundation will ... WHAT: The Sunflower Soiree, WHEN: 7 p.m. ... Corner Alley, 402 Euclid Ave., Downtown Cleveland, PRICE: $100.00/person, ... or email, ...
... thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, ... attempt are five times more likely to attempt suicide ... , The study included 165 patients aged 18-69 ... departments following a suicide attempt in Sweden. Psychiatric interviews ...
... plays a significant role in African-Americans, lack of ... by researchers at Children,s Hospital of Pittsburgh of ... of Public Health. , African-Americans are significantly ... in the February issue of Archives of ...
... development offices further Covance,s geographic reach, expand access to ... Inc. (NYSE: CVD ), one of the ... today announced the opening of three new clinical development ... Israel to further enhance the company,s global presence. ...
... vexing the health system worldwide the need ... through the Australian e-Health Research Centre (AEHRC), CSIRO ... to standardise the clinical descriptions of patient symptoms, ... around the world. , "Electronic health records will ...
Cached Medicine News:Health News:Arobella Medical Achieves ISO 13485 Medical Device Certification 2Health News:Prayers From Maria - Children's Glioma Cancer Foundation Hosts Sunflower Soiree 2Health News:Nightmares increase risk of further suicide attempts 2Health News:Children's Hospital study finds African-Americans more distrusting of research than whites 2Health News:Children's Hospital study finds African-Americans more distrusting of research than whites 3Health News:Covance Opens Three New Offices in Ukraine, Slovakia, and Israel 2Health News:Covance Opens Three New Offices in Ukraine, Slovakia, and Israel 3Health News:Australian technology in global health toolkit 2
... device the two steps are performed in ... Proteus' single use disposable cartridge and placed ... operator touches a button, and the cycle ... centrifugation. Then the integral syringe pump concentrates ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
... based upon the physiological form and ... segment unit. Kinematics and morphology of ... and anatomical aspects of the physiological ... components utilizing proven implant materials: Forged ...
Medicine Products: